Fermentation of barley flour with Lactobacillus reuteri by Pallin, Anton
Fermentation of Barley Flour with 
Lactobacillus reuteri 
A source of bioactive compounds against a leaky gut? 
Anton Pallin 
Faculty of Natural Resources and Agricultural Sciences 
Department of Microbiology 
Uppsala 
  
Licentiate Thesis 
Swedish University of Agricultural Sciences 
Uppsala 2015 
 
 
ISBN (print version) 978-91-576-9282-5 
ISBN (electronic version) 978-91-576-9283-2 
© 2015 Anton Pallin, Uppsala 
Print: SLU Service/Repro, Uppsala 2015 
Cover: Photos of cereal flour fermented with L. reuteri, colonies of L. reuteri on
MRS agar, a 1H-NMR spectrum and a light microscopy image of IPEC-J2 cells 
(photo: Anton Pallin) 
Fermentation of Barley Flour with Lactobacillus reuteri. A source 
of bioactive compounds against a leaky gut? 
Abstract 
Fermentation of foodstuffs has beneficial effects on shelf life, taste and texture and 
possibly also health of the consumer. Products containing microbes with beneficial 
health effects for the host are defined as probiotics. One probiotic bacterium, 
Lactobacillus reuteri, has been shown to exert positive effects on a number of diseases 
and disorders, including a possible protective role against increased intestinal 
permeability or ‘leaky gut’. Increased intestinal permeability has been linked to e.g. 
inflammatory bowel disease (IBD), irritable bowel disease (IBS), coeliac disease and 
infectious diarrhoea. This study examined the effect of different cereal substrates on the 
growth, general metabolism and production of potential bioactive compounds by L. 
reuteri, with the aim of establishing a synbiotic formulation effective against increased 
intestinal permeability. Combinations of six barley varieties and six strains of bacteria 
were evaluated using standard plate counts, chemical analysis (1H-NMR) and a small 
intestinal epithelial cell model (IPEC-J2). The overall growth of L. reuteri in barley 
flour was good and reached higher densities in untreated compared with heat-treated 
flours. Differences in growth were also seen between bacterial strains and barley 
varieties. The general metabolism was similar for all strains with a few exceptions, e.g. 
lower production of succinate from L. reuteri DSM 17938. Two potentially bioactive 
compounds, Ȗ-aminobutyric acid (GABA) and 3-hydroxypropionic acid (reuterin), were 
detected in barley fermented by L. reuteri. GABA was present in unfermented flour at 
similar levels as in the fermented counterpart, indicating no or low production by L. 
reuteri. Reuterin production was detected as formation of 1,3-propanediol and was 
strain-specific, being present in fermentation with DSM 17938 and ATCC PTA 6475. 
Experiments with IPEC-J2 cells revealed an increase in epithelial permeability caused 
by untreated flour, both fermented and unfermented. Treatment with heat-treated flour 
had a slight increasing effect on permeability, but recovered over time. Pre-treatments 
with live bacteria or fermented heat-treated flour before challenge with enterotoxigenic 
E. coli revealed significantly lower leakage of a molecular probe (FITC-dextran, 4 
kDa). However, neither live bacteria nor their metabolites had a protective effect on 
epithelial permeability, measured as transepithelial electrical resistance (TEER). 
Keywords: Lactobacillus reuteri, probiotics, prebiotics, synbiotics, intestinal barrier 
integrity, NMR, barley, IPEC-J2, cereal fermentation 
Author’s address: Anton Pallin, SLU, Department of Microbiology,  
P.O. Box 7025, 750 07 Uppsala, Sweden. E-mail: anton.pallin@slu.se 
 
 
Do… or do not. There is no try. 
Master Yoda 
  
 Contents 
List of Publications 7 
Abbreviations 9 
1 Introduction 11 
1.1 History of fermentations 11 
1.2 Barley (Hordeum vulgare) 14 
1.3 Prebiotics 17 
1.4 Probiotics 18 
1.4.1 Health effects of probiotics 19 
1.4.2 Lactic acid bacteria (LAB) 19 
1.4.3 The genus Lactobacillus 20 
1.4.4 Lactobacillus reuteri 21 
1.5 Synbiotics and production of bioactive compounds 23 
1.6 For a healthy intestine 25 
1.6.1 Leaky gut 26 
2 Aims 29 
3 Results and discussion 30 
3.1 Isolation of L. reuteri strains from cereals (Paper I) 30 
3.2 Characterisation and phylogenetic positioning of isolated L. reuteri 
strains (Paper I) 31 
3.3 Growth and pH reduction of L. reuteri in barley flour (Paper I) 32 
3.3.1 Bacterial counts 34 
3.3.2 pH  34 
3.4 Chemical analysis of barley fermented with L. reuteri (Paper I) 35 
3.4.1 Metabolic profiling by 1H-NMR 36 
3.4.2 Potentially bioactive compounds in fermented barley 40 
3.5 Evaluation of fermented barley in a cell model (Paper II) 41 
3.5.1 Intestinal permeability in an intestinal epithelial cell model 41 
4 Summary 43 
5 Future perspectives 45 
References 47 
Acknowledgements 59 
 
 
7 
List of Publications 
This thesis is based on the work contained in the following papers, referred to 
by Roman numerals in the text: 
I Anton Pallin, Peter Agback, Hans Jonsson and Stefan Roos. (2015) 
Evaluation of growth, metabolism and production of potentially bioactive 
components during fermentation of barley with Lactobacillus reuteri. 
Manuscript. 
II Anton Pallin, Torbjörn Lundh, Hans Jonsson and Stefan Roos. (2015) 
Metabolites produced by Lactobacillus reuteri during cereal fermentation 
prevent increased intestinal permeability caused by ETEC in vitro. 
Manuscript. 
  
8 
The contribution of Anton Pallin to Papers I and II was as follows: 
I Planned the studies with co-authors, performed most laboratory work and 
had main responsibility for writing and revising manuscript. 
II Planned the studies with co-authors, performed most laboratory work and 
had main responsibility for writing and revising manuscript. 
  
9 
Abbreviations 
ANOVA Analysis of variance 
CFU Colony-forming units 
ETEC Enterotoxigenic Escherichia coli 
FITC Fluorescein isothiocyanate   
GABA Gamma-aminobutyric acid 
GBF Germinated barley foodstuff 
GI Gastrointestinal 
HDL High density lipoprotein 
IBD Inflammatory bowel disease 
IBS Irritable bowel disease 
LAB Lactic acid bacteria 
LDL Low density lipoprotein 
MLSA Multi-locus sequence analysis 
NMR Nuclear magnetic resonance 
PCR Polymerase chain reaction 
SCFA Short-chain fatty acids 
TEER Transepithelial electrical resistance 
TJ Tight junction 
 
  
10 
 
11 
1 Introduction 
1.1 History of fermentations 
Fermentation is considered the second oldest method for preserving food in the 
world, after drying (Farnworth, 2008). It is the process of transforming simple 
raw materials into different products with added value by exploiting the growth 
and activity of microorganisms on different substrates. People soon found other 
advantages of fermentation, e.g. not only could they store their food for a 
longer time, but they could also change the taste, texture and overall sensory 
sensation of that food. Other advantages regarding health and nutritional 
benefits also emerged. Wine making allowed people to have a beverage which 
would not cause sickness, since water supplies in larger settlements could be 
contaminated. In bread making, fermenting the flour-water mixture before 
baking led to a product with better sensory qualities and more easily available 
nutrients. The history of fermented foods is thought to have begun with cheese 
and bread making as long as 8000 years ago, in present-day Iraq (Fox, 1993). 
Documentation of such early fermentation comes from writings, drawings and 
friezes. Deliberate fermentation is believed to have been used as soon as people 
started domesticating cows, sheep, goats etc. Even though they did not know 
exactly what happened, people realised that they could keep milk for longer if 
they stored it in animal stomachs. Being stored in stomachs curdled the milk 
and exposed it to lactic acid bacteria and other microbes present in the 
environment, which formed the first primitive cheeses. An advantage of 
fermented milk and other food items was that they did not have to be further 
processed, e.g. by heating or cooking. As soon as they had been fermented, 
they were ready to be consumed (Hui et al., 2003). For many thousands of 
years, people used the art of fermenting to produce different varieties of food 
items in order to extend the time for which they could store them or to achieve 
specific aromas or textures, without really knowing anything about the science 
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behind this. It would take until the mid-nineteenth century before an 
understanding of how the process works was reached, which changed the way 
in which food fermentation was performed. Two events in particular are 
considered to have been important during the nineteenth century. First, the 
Industrial Revolution changed the way in which food was produced. With 
growing populations in cities and towns, foods had to be made in larger 
quantities at an industrial scale, which changed the manufacturing process and 
demanded better knowledge of the process. At around the same time, the field 
of microbiology began to evolve as a science, which helped understand the 
biology behind fermentation and contributed to a more targeted and controlled 
approach to fermentation of foodstuffs (Caplice & Fitzgerald, 1999).  
Cereal grain has long been the most important source of dietary proteins, 
carbohydrates, vitamins, minerals and fibre for people across the planet. 
However, a few different attributes cause cereal grain to have slightly lower 
nutritional quality than milk and milk products. For example, it usually has a 
lower protein content, lacks certain essential amino acids, has low starch 
availability and may also have anti-nutrients present (phytic acid, tannins and 
polyphenols). These anti-nutrients can form complexes with minerals (iron, 
zinc, calcium and magnesium) and proteins, lowering uptake of these in the 
gastrointestinal (GI) tract (Chavan et al., 1989).  
In order to increase the nutritional value of cereal grain, a number of 
different methods have been employed, ranging from plant breeding and 
supplementation of amino acids to processing technologies. The process 
technologies used to date include cooking, sprouting, milling and fermentation 
of the grain, of which fermentation is considered to be the most effective in 
improving the nutritional value (Blandino et al., 2003). The processing of 
cereals by natural fermentation leads to the nutritional value being improved in 
a number of ways. For example, the levels of non-digestible polysaccharides 
and oligosaccharides are decreased, while amino acids and B-group vitamins 
are synthesised or increase in availability (KAZANAS & Fields, 1981). The 
pH of the fermented cereal is also decreased, which improves the enzymatic 
degradation of phytate by plant or microbial phytases, in turn increasing the 
amount of soluble minerals such as iron, zinc and calcium (Lioger et al., 2007; 
Leenhardt et al., 2005; Lopez et al., 2001). 
In addition to being able to affect the nutritional value of cereals by 
fermentation, fermentation microorganisms also improve the shelf life and 
sensory attributes (including texture, taste and aroma) of the final product 
(Figure 1). Sourdough and bread produced using specific strains of lactic acid 
bacteria (LAB) have been shown to retard the growth of moulds responsible 
for the spoilage of breads (Dal Bello et al., 2007). Fermenting cereals with 
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bacteria has also been shown to increase the concentrations of volatile 
compounds such as the aromatics ethyl acetate and diacetyl, which can impart 
a more appealing smell and taste to the final product (Damiani et al., 1996; 
Hansen & Hansen, 1994). The microbial community of fermented products can 
be quite complex and in some naturally fermented products the microbiology is 
mostly unknown. Fermented products usually contain a mixed culture of 
different bacteria, yeasts and moulds, some of which participate during the 
entire process while others only take part during some of the fermentation 
period due to changes in the dominant microbiota. The most used and most 
isolated bacteria found in fermentation include species of Bacillus, 
Lactobacillus, Leuconostoc, Micrococcus, Pediococcus and Streptococcus 
(Blandino et al., 2003). 
 
Figure 1. A selection of different fermented food items: sourdough, sour milk, red wine and 
cheese. Combined pictures from Wikimedia Commons, credited to Janus Sandsgaard, Kristofer2, 
André Karwath & Myrabella. 
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1.2 Barley (Hordeum vulgare) 
Barley (Hordeum vulgare), like all other true cereals, is a member of the grass 
family. Barley, wheat, maize, rice, rye, millet, oats, sorghum and triticale are 
the nine most important cereals grown in the world today. Globally, barley is 
the fourth most produced cereal, after maize, rice and wheat (FAOSTAT, 
2007). Barley is grown in different environments ranging from sub-Artic to 
sub-tropical and is mainly produced in temperate areas and at high altitudes of 
the tropics and subtropics. At lower altitudes of tropical areas barley is rarely 
grown, since it is not well-suited to warm, humid climates (Nevo & Shewry, 
1992). The origins of barley have been traced back almost 10 000 years to an 
area in the Middle East known as the Fertile Crescent (Badr et al., 2000). Early 
use of barley as a food dates back to the ancient Greeks, who made unleavened 
bread from barley flour. Even the Romans used barley, since they thought it a 
hearty tasting, high-energy food which would give their gladiators strength and 
stamina; the gladiators were actually called ‘hordearii’ or ‘barley men’ (Baik 
& Ullrich, 2008). During the Bronze Age (2200 years ago), barley was one of 
the major cereals grown and used for food in Scandinavia. The main reason 
why barley was cultivated in these countries was that the wheat cultivars in 
those days were not suitable for growing in cold climates. With the discovery 
of new cereals and new cultivars and the method for leavening bread by 
addition of microorganisms, the use of barley in bread making was reduced. 
The probable reason for this reduction in barley use is that other cereals such as 
wheat gave a more light and airy bread that was probably more appealing.  
Today, barley is used in breakfast cereals, stews, soups, porridge, bakery 
flour blends and baby food. In Korea, it is also used as a substitute for rice and 
for the production of soy paste and soy sauce. Most production of barley takes 
place in Europe (62%), followed by Asia (15%) and America (13%). The use 
of barley in food is very low, however. In the United States, only 1.5% of the 
barley produced is used for food and the rest is used for animal feed (65%) and 
in malt and alcohol production (30%). Figures from 1991 show that the use of 
barley for food in 12 countries in Europe averaged around 0.3%, while the use 
in e.g. China, India and Ethiopia was above 60% (Newman & Newman, 2006). 
While the present use of barley in food is low, an increase could be expected 
due to increasing health trends and an increasing number of reports on the 
possible health effects of consuming barley products 
Barley has a high nutritional value, with low fat content, complex 
carbohydrates and a protein content that covers most of the amino acid 
requirements in humans. Barley grains also include minerals, vitamins (vitamin 
E in particular), other antioxidants, e.g. polyphenolic compounds, and 
insoluble and soluble fibre (Baik & Ullrich, 2008). Barley and oats are known 
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as high-fibre cereals, with relatively high levels of ȕ-glucan compared with 
other cereals. ȕ-glucan is a soluble fibre mainly found in the endosperm wall of 
cereals (Figure 2). In barley, it constitutes 75% of the endosperm cell wall 
(Fincher, 1975) and 2-10% of the total weight (Henry, 1987). Several studies 
have examined the health effects of barley ȕ-glucans, with lowered blood 
cholesterol and glycaemic index being two promising results reported in 
clinical trials (Pins et al., 2007). Barley ȕ-glucan has also been shown to have 
an effect on weight loss by increasing satiety and by speeding up the passage 
of food in the colon (Schroeder et al., 2009; Granfeldt et al., 1994). All of 
these effects can be associated with a lower risk of heart disease and type-2 
diabetes, showing the potential health effects of supplementing a diet with 
whole-grain barley products.  
 
 
Figure 2. Figure showing a cross-section of a barley kernel with major components (hull, bran, 
endosperm and germ). 
In addition to the positive effects on blood cholesterol and glycaemic index, 
barley has also been evaluated as a prebiotic with promising results when 
treating patients with ulcerative colitis (Kanauchi et al., 2002). Both clinical 
activity and mucosal inflammation were reduced in patients with ulcerative 
Hull
Bran
Endosperm
Germ
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colitis given a daily supplementation of germinated barley foodstuff (GBF). 
Increased luminal butyrate production and stimulated growth of protective 
bacteria were suggested as the possible mechanism behind the decrease in 
inflammation. GBF has also shown promising results as an anti-tumour agent 
against colon cancer in a rat model (Kanauchi et al., 2008). Differences seen in 
the GBF group compared with the control were a significant increase in the 
production of a tumour suppressor gene (slc5a8) and in caecal butyrate content. 
Studies with weaned piglets have also shown that a feed with different 
combinations of hulless and hulled barley supplemented with ȕ-glucan could 
have a positive effect on the lactobacilli counts in the intestine (Pieper et al., 
2008). All these results suggest that the carbohydrate composition of a feed or 
a food item could have an effect on the microbial community structure in the 
intestine, or at least on a few specific species or genera of bacteria.  
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1.3 Prebiotics 
The term ‘prebiotic’ refers to “a non-digestible food ingredient that 
beneficially affects the host by selectively stimulating the growth and/or 
activity of one or a limited number of bacteria in the colon” (Gibson & 
Roberfroid, 1995). In principle, all prebiotics are fibres, but that does not 
necessarily mean that all fibres are prebiotics, since in order to be classified as 
a prebiotic a fibre has to fulfil a number of specific requirements. The food 
ingredient (or fibre) needs to be able to resist gastric acidity, hydrolysis by 
mammalian enzymes and absorption in the upper part of the gastrointestinal 
tract. Since the main purpose of the prebiotic is to stimulate the activity and/or 
growth of intestinal bacteria with a positive effect on human health, the last 
requirement of a prebiotic is that it should be fermentable by the intestinal 
microbiota. Food ingredients classified as prebiotics include non-digestible 
oligosaccharides in general and fructooligosaccharides in particular. 
Oligosaccharides that have been shown to have a prebiotic affect include 
inulin, lactulose and transgalacto-oligosaccharides (Gibson et al., 2004). 
Prebiotics are usually designed to target bacteria of the genera Bifidobacterium 
and Lactobacillus, but effects on growth and activity are more common for 
bifidobacteria, since they seem to have a preference for oligosaccharides. 
There are a number of different health effects related to the consumption of 
prebiotics. Some of these health effects can be correlated to the production of 
different short-chain fatty acids (SCFA), one of which is butyrate. Butyrate is 
the principal fuel for colonic epithelial cells and has been shown to stimulate 
apoptosis in the intestine, and may hence have a protective role against 
carcinogenesis (Sengupta et al., 2006). Prebiotics have been shown to decrease 
inflammation by stimulating the growth of lactobacilli and bifidobacteria and 
the production of e.g. lactic acid (Rumi et al., 2004). The production of lactic 
acid is considered to be able to lower the luminal pH and hence reduce the 
number of pathogenic bacteria. There are also some indications that prebiotics 
might be able to prevent the development of allergies in infants by alteration of 
the microbiota (Moro et al., 2006). However meta-analyses of studies 
examining the effect of prebiotics in preventing allergic symptoms have found 
that the quality of the effect is very low (Osborn & Sinn, 2013). Infants have 
also been shown to be less afflicted with diarrhoea, flatulence, vomiting and 
fever when administered a daily supplement of oligofructose, compared with a 
placebo group, and have higher numbers of bifidobacteria and lower numbers 
of clostridia (Waligora-Dupriet et al., 2005). A meta-analysis performed on 
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studies on obese or overweight adult patients has shown that prebiotics can 
reduce total plasma cholesterol and low density lipoprotein (LDL) 
concentrations and increase high density lipoprotein (HDL) concentrations in 
diabetic patients with overweight or obesity (Beserra et al.). Thus some 
evidence of potential health benefits of prebiotics exist, but further studies are 
needed to confirm many of these suggested effects. Barley contains a number 
of different compounds which have been shown to exhibit prebiotic effects, 
e.g. arabinoxylan, ȕ-glucan and fructan (Gullón et al., 2014; Peshev & Van den 
Ende, 2014; Mitsou et al., 2010). This makes barley interesting as a source for 
prebiotics or for use in a synbiotic formulation. 
1.4 Probiotics 
Probiotics are live microorganisms, which when administered in adequate 
amounts confer a health benefit to the host. The term probiotic is a composite 
of the Latin word ‘pro’ meaning ‘for’ and the Greek word ‘biotic’ or ‘bios’ 
meaning ‘life’, and was first used to describe growth-promoting factors 
produced by microorganisms (Lilly & Stillwell, 1965). However, it was 
Metchnikoff who in 1907 became the first scientist to claim that consuming 
microorganisms could improve people’s health. He claimed that lactobacilli in 
yoghurt could outcompete toxin-producing bacteria in the gut and thereby 
increase the human lifespan (Schrezenmeir & de Vrese, 2001). At around the 
same time, a French paediatrician named Henry Tissier observed that faecal 
samples taken from children with diarrhoea contained lower amounts of 
bacteria with a strange Y-shaped morphology. These bacteria were later named 
Bifidobacterium and, according to Tissier’s observations, they were far more 
abundant in healthy children, so he suggested administering these bacteria in 
order to restore the microbiota in the gut (Tissier, 1907). When choosing a 
microbe for use as a probiotic, there are a number of different attributes or 
factors that are important or necessary. Resistance to pancreatic enzymes, acid 
and bile are important in order for the probiotic microbe to survive the passage 
through the GI tract. Adhesion to the intestinal mucosa might also be important 
for persistence, immunomodulation, pathogen exclusion and enhanced healing 
of damaged mucosa. The microbe must be of human origin for host-specific 
interactions by the probiotic and it must of course be safe for the host. It must 
also have good technological properties such as strain stability and oxygen 
tolerance, and must be able to be produced on an industrial scale. Last but not 
least, the intended probiotic strain must have a documented health effect.  
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1.4.1 Health effects of probiotics 
The use of probiotics has been linked to a number of positive health effects. 
These effects can be divided into well-documented outcomes with good 
evidence according to meta-analyses and promising, but not fully proven, 
health effects with low evidence or where no meta-analyses have been 
performed. Well-documented health effects with good evidence include: 
 
¾ Lower frequency and duration of diarrhoea connected to use of 
antibiotics (Johnston et al., 2011) or caused by an infectious agent 
(Allen et al., 2010) 
¾ Reduction of Helicobacter pylori infection (Tong et al., 2007) 
¾ Relief from constipation (Dimidi et al., 2014) 
¾ Relief from irritable bowel syndrome (IBS) (Ortiz-Lucas et al., 2013) 
¾ Reduction of total and LDL cholesterol plasma concentrations (Guo et 
al., 2011) 
¾ Treatment of colic symptoms in breastfed infants (Anabrees et al., 
2013). 
 
Health effects for which further evidence is needed include: 
 
¾ Prevention of allergic disease and food hypersensitivity (Osborn & Sinn, 
2007) 
¾ Maintenance of remission in ulcerative colitis (Naidoo et al., 2011; Sang 
et al., 2010) and Crohn’s disease (Butterworth et al., 2008) 
¾ Treatment of colic symptoms in formula-fed infants (Anabrees et al., 
2013). 
 
In 2002, more than 19 species from seven different genera of bacteria and yeast 
were used as probiotics and had documented health effects (Ouwehand et al., 
2002). However, the list of microbes used in probiotic products has grown 
continually since then and the exact number is currently unknown. The most 
commonly used strains belong to the LAB, but there are also species from the 
genera Escherichia, Bacillus and Propionibacterium. What is important to 
know is that the health effects seen when using microbes in probiotic products 
are usually strain-specific and that there can be a huge difference in probiotic 
potential even within a single species of microbes.  
1.4.2 Lactic acid bacteria (LAB) 
The group of LAB consists of Gram-positive cocci or rod-shaped bacteria, 
which are non-sporulating and non-respiring. The name ‘lactic acid bacteria’ is 
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used since they all produce lactic acid as the major end-product during 
fermentation of carbohydrates. Genera included in this group are: Aerococcus, 
Carnobacterium, Enterococcus, Lactobacillus, Lactococcus, Leuconostoc, 
Oenococcus, Pediococcus, Streptococcus, Tetragenococcus, Vagococcus and 
Weissella. The first pure culture of an LAB was obtained in 1873, but the 
systematic classification of the group remained slightly unclear until 1919 and 
the work of Orla-Jensen. The characteristics used by Orla-Jensen as the basis 
for classification included morphology (cocci or rods), mode of glucose 
fermentation (homo- or hetero- fermentation), minimum, maximum and 
optimum growth temperature and range of sugar utilisation. These 
characteristics are still used in the classification of LAB with a few additions, 
e.g. configuration of the lactic acid produced, ability to grow at high salt 
concentrations, acid or alkaline tolerance and fatty acid composition and 
constituents of the cell wall (Axelsson, 2004). 
The industrial use of LAB has changed greatly through the years, but they 
have always been important as starter cultures in dairy processes. These 
starters can be single-strain, multiple strains of one species, multiple strains of 
different species or raw mixed strains where the strains are partly known or 
unknown. Starter cultures contribute to the final product by changing the 
sensory experience and also extend the shelf life of the food item. This is done 
by flavour synthesis, pH reduction, protein hydrolysis that causes changes in 
texture and taste, synthesis of texturising agents which influence the 
consistency of the product and production of inhibitory components. These 
characteristics and activities are also important in the fermentation of meat, 
vegetable and cereal products (Mäyrä-Mäkinen et al., 1993). In bread making, 
the fermentation by LAB has a number of different functions, including 
making the dough easier to bake, giving a more appealing and softer bread 
crumb and control and inhibition of contaminating or spoiling microorganisms 
during the fermentation and in the bread e.g. elongation of mould-free time 
during storage of bread (Salovaara et al., 1993). LAB can also contribute to a 
better end-product by producing flavour, aromas and increasing mineral 
availability, as mentioned earlier. Different species of LAB belonging to at 
least three different genera (Bifidobacterium, Enterococcus and Lactobacillus) 
are commonly used as probiotic supplements and the majority of these belong 
to the genus Lactobacillus (Ouwehand et al., 2002). 
1.4.3 The genus Lactobacillus 
The genus Lactobacillus belongs to the phylum Firmicutes, the class Bacilli, 
the order Lactobacillales and the family Lactobacillaceae. Lactobacilli are rod-
shaped, oxygen-resistant anaerobes which are chemo-organotrophic and 
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require a rich medium to grow. They can be found in a variety of different 
environments ranging from foods to the respiratory, GI and genital tract of 
humans and animals, sewage and plant material. This genus is among the 
largest of the bacterial genera, with approximately 225 known species (Euzéby, 
2014-11-07), one of which is the GI-tract associated and probiotic species 
Lactobacillus reuteri. 
1.4.4 Lactobacillus reuteri 
Lactobacillus reuteri was first described as a species by Kandler et al. (1980). 
However, back in 1962 it had been recognised as a distinct “type” and was then 
regarded as Lactobacillus fermentum biotype II (Kandler et al., 1980). 
Lactobacillus reuteri is a rod-shaped bacterium which normally resides in the 
GI tract of humans and a number of other animal species, including poultry, 
pigs, dogs, rodents etc. (Hammes & Hertel, 2006). In the gut of pigs, rodents 
and chickens, L. reuteri seems to be one of the most abundant species and has 
been shown to be present in a large subset of animals (Walter et al., 2011). The 
prevalence of L. reuteri in the human gut seems to be much lower, however, 
and it is only detected occasionally. Despite this, it is present not only in the GI 
tract of humans, but also in breast milk, the oral cavity and the vagina. In 
addition to being a stable member of the microbiota in humans and animals, L. 
reuteri has also frequently been isolated in high temperature sourdoughs. 
However, these isolates are believed to originate from faecal contaminants of 
rodent origin (Su et al., 2012). Through being present in so many different 
warm-blooded animals, L. reuteri has adapted to being highly host-specific in 
terms of phenotypic characteristics. Its different phenotypic characteristics 
include e.g. ability to adhere to epithelial cells and production of certain 
enzymes or anti-microbial substances (Walter et al., 2011). Like other 
lactobacilli, L. reuteri is a highly demanding species and requires easily 
fermentable sugars, amino acids, vitamins and nucleotides. With all these 
requirements met, L. reuteri has a duplication time of less than one hour (Gerez 
et al., 2008). The species uses the phosphoketolase pathway for fermentation 
of carbohydrates to form lactate, acetic acid, ethanol and carbon dioxide. This 
pathway has low energetic yield, but L. reuteri uses external electron acceptors 
such as fructose, glycerol, pyruvate, citrate, nitrate and oxygen to improve this. 
Even though it is a highly demanding species, L. reuteri has been shown to 
resist and survive in environments with low pH and in the presence of bile 
salts, which are important characteristics for a probiotic strain (Whitehead et 
al., 2008; Jacobsen et al., 1999). 
Other characteristics of L. reuteri that make it a good candidate as a 
probiotic strain include the fact that it can compete with other microorganisms 
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by the production of several antimicrobial substances. Lactic acid and acetic 
acid, which are produced during normal carbohydrate degradation, can inhibit 
the growth of microbes and are especially potent against Gram-negative 
bacteria. In addition to these normally produced metabolites, some strains of L. 
reuteri are known to produce a broad-spectrum antimicrobial metabolite named 
reuterin. This compound is a low molecular weight, water-soluble, non-
proteinaceous and neutral end-product associated with the fermentation of 
glycerol to 1,3-propandiol and can be accumulated and secreted by L. reuteri 
under certain conditions (Spinler et al., 2008). Reuterin is a mixture of 3-
hydroxypropionaldehydes (3-HPA) and includes a monomer, a hydrated 
monomer and a cyclic dimer. It is formed during anaerobic growth by a two-
step pathway where glycerol is first dehydrated to form reuterin, some of 
which is further reduced to 1,3-propanediol. The reduction of reuterin to 1,3-
propanediol is proposed to generate NAD+ from NADH and hence contribute 
to improved growth (Schaefer et al., 2010). It has been shown that the presence 
of other bacteria such as Escherichia, Salmonella, Shigella, Proteus, 
Staphylococcus, Clostridium and Pseudomonas stimulates this conversion of 
glycerol to reuterin and that it provides L. reuteri with a competitive advantage 
in the intestinal tract (Schaefer et al., 2010; Chung et al., 1989). Reuterin has 
been proven to inhibit the growth of Gram-negative and Gram-positive 
bacteria, as well as yeasts, fungi and protozoa, and also to have an effect 
against viruses (Walter et al., 2011; Schaefer et al., 2010; Jacobsen et al., 
1999; Axelsson et al., 1989). In addition, some strains of L. reuteri have been 
observed to produce yet another low molecular weight antimicrobial substance 
named reutericyclin, a tetramic acid that has been shown to be bacteriostatic or 
bactericidal to Gram-positive bacteria. However, Gram-negative bacteria and 
yeast seem to be resistant to reutericyclin due to the barrier properties of their 
outer membrane (Gänzle et al., 2000). 
Numerous clinical studies have proven the potential of L. reuteri as a 
probiotic species. Studies have shown that supplementation with L. reuteri can 
alleviate GI tract symptoms and improve colicky symptoms in breastfed infants 
(Indrio et al., 2014; Savino et al., 2010), reduce infections (Tubelius et al., 
2005; Weizman et al., 2005) and improve feeding tolerance in formula-fed 
premature neonates (Indrio et al., 2008). Other studies have reported promising 
results in treating children with ulcerative colitis (Oliva et al., 2012) and 
decreasing the number of days with diarrhoea in children treated with a daily 
supplement compared with untreated groups (Gutierrez-Castrellon et al., 2014; 
Weizman et al., 2005). Children with acute rotavirus-induced diarrhoea also 
have a reduced duration of watery diarrhoea when supplemented with L. 
reuteri (Shornikova et al., 1997). In addition to having an effect on infants and 
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children, L. reuteri has been shown to suppress infections caused by 
Helicobacter pylori in adults. Treatment with L. reuteri reduced the overall 
occurrence of dyspeptic symptoms, abnormal defecation and flatulence in these 
patients compared with a group receiving a placebo (Francavilla et al., 2014; 
Francavilla et al., 2008). Besides being able to reduce the occurrence of 
symptoms in various diseases and disorders, L. reuteri has been proven to 
reduce the transport of live bacteria from the intestinal lumen to the 
bloodstream and internal organs of the body (Wang et al., 1995). This 
phenomenon, called bacterial translocation, can be caused by bacterial 
pathogens or by members of the normal gut microbiota when the host is 
exposed to stressful conditions such as starvation, trauma etc. Studies have also 
shown a positive effect in maintaining gut mucosal integrity after treatment 
with L. reuteri (Adawi et al., 1997). 
1.5 Synbiotics and production of bioactive compounds 
The term ‘synbiotic’ is used when a product contains both probiotics and 
prebiotics and was coined at the same time as the term prebiotics in 1995 
(Gibson & Roberfroid, 1995). The definition of a synbiotic is still under 
revision, since there is some divided opinion regarding whether the prebiotic 
included in the synbiotic formulation should promote the growth and/or 
activity of the partner probiotic. There have been a number of different studies 
on synbiotic formulations to investigate whether the viability and persistence 
of a probiotic bacterium could be enhanced by supplementing it with a 
prebiotic compound. Studies on mice have shown that different kinds of 
prebiotics, e.g. soybean oligosaccharide, fructooligosaccharides and inulin, can 
significantly enhance the survival and number of bacteria, as well as 
prolonging the retention time of probiotic strains such as Lactobacillus 
acidophilus, Bifidobacterium animalis subsp. lactis and Lactobacillus casei 
(Su et al., 2007). On the other hand, clinical studies on humans have shown 
that a synbiotic formulation can lead to an increase in a completely different 
species than the probiotic supplied in the synbiotic formulation itself (Piirainen 
et al., 2008). These studies show the importance of having a well-established 
synbiotic formulation, but also that the effect can be difficult to predict because 
of the complex environment in the intestinal tract. As mentioned in the 
previous section, probiotics have been shown to improve some of the 
symptoms related to IBS. However, there have been very few studies published 
indicating that the use of prebiotics alone could have the same effect. 
Combinations of probiotics and prebiotics have been shown to decrease a 
number of different symptoms in IBS patients, including nausea, flatulence and 
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colitis (Bittner et al., 2005). Other studies have shown that combinations of 
lactobacilli, bifidobacteria and fructooligosaccharides can reduce the incidence 
of common infectious diseases in children during the winter period and thereby 
the number of days the children have to stay away from school (Cazzola et al., 
2010). Effects have also been seen on the plasma cholesterol levels in human 
subjects, where a synbiotic formulation containing lactobacilli and inulin 
reduced the total and LDL cholesterol levels (Ooi et al., 2010).  
In addition to enhancing the growth and persistence of bacteria, it might 
also be possible to enhance the effect of probiotics on human health by 
enhancing the production of certain health promoting agents or bioactive 
compounds by the probiotic bacteria. Bioactive compounds (also referred to as 
nutraceuticals) are naturally occurring substances that are part of the diet and 
can be essential or non-essential, but should have an established effect on 
human health. They can be isolated nutrients or parts of dietary supplements, 
genetically engineered ‘designer’ foods, herbal products or processed foods, 
e.g. cereals, soups and beverages (Biesalski et al., 2009). Bioactive compounds 
can be present in different food ingredients, but they are not always available 
to the host. In cereals, the phenolic acids present are mainly bound to 
arabinoxylans through ester bonds and these fibre-bound phenolic acids cannot 
be hydrolysed by human digestive enzymes (Saura-Calixto, 2010). Studies 
have shown that probiotic bacteria such as L. reuteri can release these phenolic 
acids and possibly make them accessible to the host. Barley and oat flour 
fermented by different species of lactobacilli, including L. reuteri, can increase 
the bioavailability of certain dietary phenolic acids such as caffeic, coumaric, 
ferulic and sinapic acid (Hole et al., 2012). Similar results have been seen for 
cowpea flour fermented with L. plantarum, which leads to an improvement in 
phenolic compound concentration and antioxidant activity (Dueñas et al., 
2005), and in rye flour fermented with baker’s yeast, L. brevis and L. 
plantarum, which gives higher concentrations of folate and phenolic 
compounds (Liukkonen et al., 2003). Concentrations of other bioactive 
compounds such as Ȗ-aminobutyric acid (GABA) have also been shown to 
increase on fermenting different kinds of cereals or sub-cereals with 
lactobacilli (Stromeck et al., 2011; Coda et al., 2010). Another effect is the 
production of SCFA, which are associated with reduced risk of diseases such 
as cancer, cardiovascular disease and inflammatory bowel diseases (Floch & 
Hong-Curtiss, 2002; Jenkins et al., 1999). 
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1.6 For a healthy intestine 
In sheer cell numbers, the human body consists to a large degree of its 
microbiome, which is "the ecological community of commensal, symbiotic, 
and pathogenic microorganisms that literally share our body space” (Lederberg 
& Mccray, 2001). The human body consist of around ten times as many 
bacterial as human cells (Savage, 1977). In the gastrointestinal tract alone more 
than 400 bacterial species have been found, but more recent studies claim that 
there could be as many as 1000 different species of bacteria present (Rajiliü-
Stojanoviü et al., 2007). Most of these bacteria are found in the GI tract, 
ranging from 103 colony forming units (CFU) per ml gastric juice in the 
stomach and increasing throughout the intestine, reaching the highest 
concentrations (1012 CFU per gram faeces) in the colon (Mitsuoka, 1992). One 
reason that the GI tract can house such a great number of bacterial cells is 
because it is one of the body’s largest external surfaces, measuring a total of 32 
m2, the size of half a badminton court (Helander & Fändriks, 2014). In human 
foetuses these surfaces have long been considered to be sterile until birth and it 
was once widely accepted that the colonisation of the human body occurs 
during and after birth (Mackie et al., 1999). However, more recent studies  
suggest that there is some exchange between the mother and foetus, suggesting 
that the foetus might not be completely sterile (Jiménez et al., 2008). The 
composition of the intestinal microbiota is set at an early age (Palmer et al., 
2007) and is considered to remain relatively stable in a healthy person 
throughout life (Rajiliü-Stojanoviü et al., 2013). However, the composition can 
be disturbed and changed by different factors, such as physiological state, 
drugs, disease, diet and stress (Lozupone et al., 2012; Mitsuoka, 1992). The 
importance of having a stable intestinal microbiota to avoid disease has been 
shown in studies as far back as the 1950s on mice and guinea pigs. Bohnhoff et 
al. (1954) showed that oral administration of antibiotics to mice made them 
more susceptible to Salmonella infections (Schrezenmeir & de Vrese, 2001). 
Similar experiments performed in 1955 on guinea pigs showed that 
administration of a specific antibiotic rendered the animals more susceptible to 
Vibrio cholerea (Freter, 1955).  
In addition to playing an important role against pathogenic microorganisms, 
changes or differences in the composition of the microbiome have been linked 
to a number of different diseases and syndromes. Obesity, circulatory disease, 
inflammatory bowel disease and autism are just a few examples of diseases or 
physical or psychological states where a difference in the microbiome 
composition has been seen compared with healthy subjects (Finegold, 2008; 
Holmes et al., 2008; Marchesi et al., 2007; Turnbaugh et al., 2006). The 
intestinal microbiome has also been shown to have an influence on drug 
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metabolism and toxicity, dietary calorific bioavailability and recovery after 
surgery (Kinross et al., 2010; Clayton et al., 2006; Hooper & Gordon, 2001). 
One effect that disruption of the normal microbiome or dysbiosis can lead to is 
a syndrome called ‘leaky gut’, which in turn has been linked to a number of 
different diseases (Frazier et al., 2011; Sartor, 2008). 
 
Figure 3. Simplified overview of the structure of a small intestine, showing a) the gastrointestinal 
tract, b) intersection of the small intestine with its folds, c,d) villi and e)  individual epithelial cells 
with microvilli. The epithelial layer is comprised of a single cell layer where the paracellular 
space is sealed by tight junction proteins (TJ) the function of which is to limit the leakage of 
unwanted substances or microorganisms. A leaky gut, or increased intestinal permeability, can be 
caused by TJ with a disturbed function, leading to microbes entering the lamina propria. 
1.6.1 Leaky gut 
The more scientific term for leaky gut is increased intestinal permeability and 
it refers to the intestine’s ability to prevent harmful substances from entering 
the internal environment of the body or, in the case of disease, the inability of 
the intestine to prevent leakage of these harmful substances (Bjarnason et al., 
1995). The gastrointestinal wall consists of different barriers to prevent 
unwanted substances or microorganisms from entering the blood stream. The 
epithelial layer itself consists of two barriers (see Figure 3), the first of which is 
the cell membrane itself. The cell membrane consists of lipids and does not 
allow water-soluble substances to pass through. The second barrier can be 
found between each cell, in an area called the paracellular space which is 
controlled by proteins called tight junction (TJ) proteins. These can open and 
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close to allow fluids, nutrients and even microorganisms to cross from the 
lumen into the lamina propria of the intestine (Madara & Pappenheimer, 1987). 
Tight junctions with a disturbed function caused e.g. by a disease result in 
increased intestinal permeability or leaky gut. 
In the 1980s, Crohn’s disease and coeliac disease were investigated in order 
to establish whether they caused increased intestinal permeability. These early 
studies revealed that patients suffering from Crohn’s disease had increased 
intestinal permeability to larger-sized molecules such as lactulose. However, 
no change in the permeability of smaller molecules, such as mannitol or 
rhamnose, was seen in these patients (Ukabam et al., 1983; Pearson et al., 
1982). A similar increase in permeability to larger-sized molecules was seen in 
patients with coeliac disease, while for smaller molecules such as mannitol a 
decrease in permeability was seen in these patients (Ukabam & Cooper, 1984; 
Bjarnason et al., 1983). By eliminating gluten from their diet, the intestinal 
permeability of these patients was normalised. Other disorders and diseases 
have also been suggested to be connected to an increase in intestinal 
permeability, including food allergies, asthma and some allergic skin 
conditions. In addition, patients with severe general trauma, patients who have 
undergone major surgery and burn patients have been demonstrated to have 
abnormalities in intestinal permeability (Hollander, 1999). Moreover, an 
increase in intestinal permeability has been reported in patients suffering from 
other gastrointestinal disorders. For example, patients suffering from 
diarrhoea-predominant IBS have been shown to have a higher ratio of 
lactulose/mannitol in their urine samples compared with controls, suggesting 
greater leakage of lactulose. Several studies have reported this increase in 
permeability in patients with IBS and some have even reported correlations 
between an increase in permeability and abdominal pain (Zhou et al., 2009; 
Dunlop et al., 2006; Spiller et al., 2000).  Understanding and being able to 
measure intestinal permeability is important in prevention and early detection 
of all these diseases and disorders. Protection against a reduction in the 
protective barrier function is highly important, since it is involved in e.g. 
several gastrointestinal diseases and allergies. 
The possible role of probiotics in decreasing intestinal permeability in 
patients suffering from different diseases and disorders has been evaluated in a 
number of studies. Supplements of probiotic lactobacilli (L. rhamnosus 19070-
2 and L. reuteri DSM 12246) given to children with atopic dermatitis resulted 
in a decrease in gastrointestinal symptoms and intestinal permeability in 
patients with severe to moderate atopic dermatitis compared with the placebo 
group (Rosenfeldt et al., 2004). Treatment of children suffering from mild to 
moderately active Crohn’s disease with Lactobacillus rhamnosus GG resulted 
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in a lower disease score and an improvement in intestinal barrier function, with 
lower permeability (Gupta et al., 2000). Pre-term infants, who have been 
shown to have increased intestinal permeability, exhibited a decrease in 
permeability after treatment with B. animalis subsp. lactis-supplemented pre-
term formula (Prenan Nestlé BLSPF) (Stratiki et al., 2007). Probiotics 
including L. plantarum and L. reuteri have also been shown to prevent the 
increased intestinal permeability caused by Escherichia coli in mice and in 
intestinal epithelial cell models (Liu, 2013; Mangell et al., 2002).   
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2 Aims 
The use of probiotics is increasing among the public. Although these are still 
classified as foods or food supplement, they have been shown to be effective in 
the prevention and treatment of a number of diseases and conditions as 
described in the previous chapter. The main hypothesis examined in this thesis 
was that in order to exploit the full potential of a probiotic bacterium, it needs 
to be metabolically active in the intestine and that the probiotic effect can be 
enhanced if appropriate nutritional compounds are provided to L. reuteri. In 
order to test this main hypothesis, three sub-hypotheses were formulated: 1) L. 
reuteri grows well in cereal substrates and produces bioactive compounds; 2) 
production of these bioactive compounds is strain-specific and can be 
enhanced by using certain cereal varieties; and 3) some of these bioactive 
compounds have a protective effect against increased intestinal permeability. 
To test these hypotheses, the following objectives were established: 
¾ Isolation of new L. reuteri strains from sourdough fermented at high 
temperature (Paper I) 
¾ Typing and characterisation of isolated strains (Paper I) 
¾ Comparison of the growth of L. reuteri strains of different origins on 
different cereal varieties (Paper I) 
¾ Comparison of metabolites of each strain in cereal varieties to find 
possible bioactive compounds (Paper I) 
¾ Determination of the effect of cereal-reuteri combinations on 
intestinal permeability using a cell culture model (Paper II) 
¾ Correlation of possible effects in the cell culture model to the 
metabolic profile of the cereal-reuteri combinations (Paper II). 
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3 Results and discussion 
Previous studies have established that L. reuteri can be isolated from industrial 
sourdoughs and that they can even dominate these sourdoughs (Meroth et al., 
2003). Studies have also been conducted on the growth and metabolism of L. 
reuteri in different kinds of cereal, many of these studying the production of 
bioactive compounds during the fermentation of cereals. Since the occurrence 
of L. reuteri is common even when using spontaneously fermented dough, one 
of the first objectives in this thesis was to isolate and if possible identify the 
origin of these strains. 
3.1 Isolation of L. reuteri strains from cereals (Paper I) 
A total of 15 different flours were analysed for the presence of lactobacilli and 
more specifically L. reuteri. Flours made from different cereals (barley, 
buckwheat, millet, rye, sorghum and wheat) were used, as well as both 
conventionally grown and organic flours. Most of the flours (nine) were 
Swedish brands, four were German and two were Chinese. Flour-water 
mixtures were prepared and incubated at 37 and 40 ºC. Isolation and 
identification were performed using selective medium (Rogosa-vancomycin), 
reuterin-specific PCR and finally 16S rRNA gene sequencing. Lactobacillus 
reuteri could not be detected or isolated from any of the nine Swedish flours or 
three of the German flours. However, in the two Chinese flours (buckwheat 
and millet) and in one German flour (organic rye), L. reuteri was detected by 
PCR. After isolation on selective medium, a total of 18 colonies were collected 
and identified using reuteri-specific PCR. These isolates were divided into five 
groups using genomic fingerprinting (rep-PCR) and later identified as L. 
reuteri by 16S rRNA gene sequencing (Table 2 in Paper I). According to these 
results, the occurrence of L. reuteri in flour seems to depend on the 
geographical origin of the flour (Paper I). Previous studies have reported the 
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presence of L. reuteri in only a few different cereals (rye, teff and sorghum) 
from a few countries (Denmark, Germany, Ireland and Sudan) (De Vuyst et al., 
2014). 
3.2 Characterisation and phylogenetic positioning of isolated L. 
reuteri strains (Paper I) 
In order to determine the possible origin of the strains isolated from fermented 
cereals, a number of different analyses were performed. Since some strains of 
L. reuteri can produce the antimicrobial substance reuterin and this ability to 
some extent correlates with the origin of the strain, a reuterin assay was 
performed on all isolates. A PCR for analysing the presence of a gene (pduC) 
involved in the production of reuterin and a gene (ureC) involved in the 
production of urease was performed (since these genes are also correlated with 
the origin). To further characterise and compare the new strains with strains of 
other origin, multi-locus sequence analysis (MLSA) was performed on one 
isolate from each of the five groups and compared against a total of 84 
previously isolated strains of different animal origin. In this analysis, the 
sequences of seven house-keeping genes were compared, as previously 
performed on L. reuteri strains isolated from different animals and also 
fermented cereals. 
All isolates gave a negative result in the reuterin assay and for the presence 
of the gene pduC, but a positive result for the presence of the gene ureC (Table 
2 in Paper I). Other studies have shown that strains of rodent origin generally 
test negative for reuterin and positive for urease (Walter et al., 2011). The 
MLSA showed that all strains clustered together with strains of rodent origin, 
two (strain SU7-3 and SU12-3) within clade I and three (strain SU3-3, SU17-3 
and SU18-3) within clade III (Figure 1 in Paper I). Since the MLSA, urease 
PCR and reuterin PCR results all showed that the new strains were similar to 
strains of rodent origin, it is likely that faecal contamination by rodents 
occurred during storage of the cereals. Lactobacillus reuteri is mainly found in 
the intestine of different animals and has never been isolated from plants or 
plant-derived products except sourdoughs, and therefore this conclusion is 
plausible. The possible rodent origin of strains isolated from sourdough has 
been noted in other studies using MLSA, which also showed that L. reuteri 
contamination could be of human origin (Su et al., 2012). 
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3.3 Growth and pH reduction of L. reuteri in barley flour (Paper 
I) 
It is already a well-established fact that L. reuteri grows well in different 
cereals, including barley, oat, rye and wheat (De Vuyst et al., 2014; Hole et al., 
2012; Charalampopoulos et al., 2002). Only a few studies have compared the 
growth of single strains of L. reuteri to that of other species of lactobacilli in 
different cereals. One of these studies has shown that L. reuteri (NCIMB 
11951) grows to a lower maximum density than L. plantarum (NCIMB 8826), 
L. fermentum (NCIMB 12116) and L. acidophilus (NCIMB 8821) in barley- 
and wheat-based substrates (Charalampopoulos et al., 2002). On the other 
hand, another study has shown that L. reuteri (LTH2584) can grow to similar 
densities as L. sanfranciscensis (LTH2581) in wheat-based substrates (Gänzle 
& Vogel, 2003). Differences (as much as 2 log10) in final growth density of L. 
reuteri have been reported in different studies using similar cereal substrates. 
Since no single study has analysed the growth of more than one strain of L. 
reuteri in cereal substrates, questions regarding the growth of L. reuteri in 
cereals remain unanswered. To answer questions regarding strain specificity in 
growth and activity in cereal substrates, in this thesis strains of different origin 
grown in slightly different cereal substrates were compared. In the analysis 
(Paper I), six barley varieties with slightly different carbohydrate composition 
were available as milled flour. Differences were mainly seen in fibre and starch 
content and also in starch, with different amylose/amylopectin ratio (Table 1 in 
Paper I). In addition to the six barley varieties, a total of six bacterial strains 
were selected for analysis. These comprised: Three L. reuteri strains isolated 
from sourdoughs, a strain representing each rodent clade (SU12-3 and SU18-3) 
and a strain previously isolated from sourdough (LTH 5531, a gift from 
Christian Hertel); two L. reuteri strains (ATCC PTA 6475 and DSM 17938) 
which are commercially available probiotic strains of human origin; and, in 
order to allow comparison with another species and determine whether growth 
and activity was species-specific, one strain of L. plantarum (36E).   
In order to analyse the activity of the added bacteria specifically and not the 
combined effect of the added bacteria and the endogenous microbiota and 
enzymes, the flour was also heat-treated to inactivate the enzymes and 
microorganisms. In all, a total of 72 combinations of barley and bacteria were 
analysed. Mixtures of water and flour were inoculated with overnight cultures 
of each bacterium, incubated at 37 ºC and subjected to back-slopping three 
times before the actual analysis. A sample was taken at the start and after 3, 6 
and 24 hours to analyse bacterial growth and pH. After the last sampling, the 
sourdoughs were centrifuged and the supernatant was collected for use in 
chemical analysis (Figure 4). 
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Figure 4. Schematic overview of the experimental procedure used in this study. Whole grain 
flours from six barley varieties were heat-treated and left untreated before fermentation by six 
bacterial strains. Fermentation ran for 24 hours at 37 °C and was performed in triplicate, giving a 
total number of 216 samples. Samples were subjected to different measurements including pH, 
bacterial growth followed by metabolic profiling and evaluation in an in vitro model using small 
intestinal epithelial cells (IPEC-J2). 
=
3x (replicates)
6 strains 6 varieties
x
2x (Heat-treated and Untreated)
x
x
Metabolic profiling (1H-NMR)
Evaluation in vitro 
(IPEC-J2)
216 samples
Incubation (24 h, 37°C)
Measurements
Bacterial growth (CFU)pH
34 
3.3.1 Bacterial counts 
All strains grew well in both untreated and heat-treated flour, reaching a final 
bacterial cell count of 9.0-9.7 log10 CFU/g in untreated flour and 7.3-9.3 in 
heat-treated flour (Table 3 in Paper I). Statistical analyses were performed to 
identify significant differences in growth between bacteria in different barley 
varieties.  
All strains grew better in untreated than in heat-treated flour, but L. reuteri 
seemed to grow less well in heat-treated flour than L. plantarum 36E. Since 
some enzymes, e.g. amylase, were inactivated during the heat treatment, lower 
amounts of monosaccharides, e.g. glucose, maltose and fructose, should have 
been made available to the bacteria. Most of the carbohydrates in cereals are in 
the form of polysaccharides and oligosaccharides such as starch, beta-glucan 
and fructan, all of which, as far as we know, L. reuteri cannot degrade. These 
two factors could explain the lower growth seen in heat-treated flour. The 
analysis also revealed similarities and differences at strain level. In untreated 
flour the differences in growth were less pronounced than in heat-treated flour, 
with growth density varying by 0.5 log10 CFU/g at most between untreated 
flour from different barley varieties. In heat-treated barley flour larger 
variations in growth density could be seen. This was especially the case for 
DSM 17938, for which growth density ranged from 7.3-8.8 log10 CFU/g, a 
difference of 1.5 log10, while the other strains showed differences in growth of 
0.4-0.7 log10. This could suggest that DSM 17938 is more dependent on 
available monosaccharides and disaccharides than the other L. reuteri strains 
and hence relies more on the presence and activity of enzymes in the flour for 
the degradation of polysaccharides and oligosaccharides. 
3.3.2 pH 
The reduction in pH was also significantly different when the bacteria were 
grown in heat-treated compared with untreated flour. In untreated flour, the pH 
reached 3.4-3.7 and in heat-treated flour it reached 3.9-5.3 after 24 hours of 
fermentation. As found for bacterial counts, the pH was lower in heat-treated 
flours fermented with L. plantarum 36E than with L. reuteri strains. Growth to 
a lower density is correlated with higher pH for lactobacilli, since if the 
bacteria have lower amounts of available monosaccharides they produce lower 
amounts of lactate and acetate as end-products. Significant differences in pH 
were found between strains of L. reuteri in both untreated and heat-treated 
barley flour (Figure 2 in Paper I). Comparing the pH reduction in each strain 
alone in the barley varieties did not reveal any differences in untreated flour 
(Table 3 in Paper I). However, differences were found in heat-treated flour 
when comparing the pH in all the barley varieties for each strain (Table 4 in 
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Paper I), suggesting that the difference in pH reduction is greater between 
barley varieties when heat-treated flours are fermented. These results suggest 
that the production of acids is both species- and strain-specific, at least when 
the bacteria are grown on heat-treated barley flour. The differences in pH seen 
in heat-treated flours could be due to differences in available sugars. The 
endogenous enzymatic activity in untreated barley flour causes a steady flow of 
monosaccharides to be made available from the degradation of e.g. starch. The 
inactivation of enzymes in heat-treated flour leaves the bacteria with only the 
free monosaccharides and disaccharides, however, since e.g. no amylases are 
available to degrade the starch. Enzymes with the ability to hydrolyse starch, 
one of which is called pullulanase, are present in some species of 
Lactobacillus. Pullulanase is able to produce maltose, amylose and glucose by 
debranching starch. In L. reuteri, the only form of this type of enzymes that has 
been detected so far is neopullulanase and the presence of the gene for this 
enzyme seems to be strain-specific, e.g. it is present in ATCC PTA 6475, but 
not in ATCC 55730 (Saulnier et al., 2011). Neopullulanase has been reported 
to be able to hydrolyse pullulan, but whether it has a function in the 
degradation of starch and what that function is remain to be determined. Some 
studies claim that it is important in the degradation of starch, while others 
claim that it does not have any effect on starch (Hii et al., 2012; Saulnier et al., 
2011; Park et al., 2000). The presence of the gene for neopullulanase in the 
other strains used in this study and expression of this enzyme could help 
explain some of the differences in growth in heat-treated flour observed 
between strains.  
3.4 Chemical analysis of barley fermented with L. reuteri (Paper 
I) 
After 24 hours of incubation, the fermented barley flours were centrifuged and 
the supernatant was collected for use in chemical analysis. The choice of using 
1H-NMR as the method for analysing the different samples was based on the 
fact that it would give the best overview of metabolites produced during 
fermentation. A total of 216 pH-adjusted samples were analysed and 
metabolites were manually identified using the NMR spectra of known 
compounds in the compound library of the software Chenomx NMR suite, as 
well as using data available in internet browser databases such as the Human 
Metabolome Database (HMDB) and the Biological Resonance Data Bank. 
Results consisting of name and concentrations of identified compounds were 
analysed using multivariate statistics to evaluate differences between samples 
and find possible correlations (Figures 3-5 in Paper I). Compounds responsible 
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for the separation of groups of samples were further analysed by ANOVA to 
identify significant differences between individual samples. 
Table 1. Final growth density of L. reuteri strains in untreated and heat-treated flour in relation 
to sugar content (SC), electron acceptor content (EAC) and total amino acid content (AAC) in 
unfermented barley flour. Growth data are mean values of samples taken after 24 hours 
incubation and are given as log10 CFU/g. Values sharing footnote letters are not significantly 
different (Student’s t-test at alpha 0.05).  SC = sum of the concentrations (mM, in 5-fold diluted 
sourdough solution) of glucose, maltose and sucrose. EAC = sum of the concentrations of 
fructose, fumarate and malate. AAC = sum of concentrations of alanine, asparagine, aspartate, 
isoleucine, leucine, phenylalanine, proline, tyrosine and valine. 
 Barley 
variety 
DSM 
17938  
ATCC PTA 
6475 
LTH 
5531 
SU12-
3 
SU18-
3 
SC  EAC  AAC 
Untreated 120 9.2BC 9.6A 9.5AB 9.5AB 9.0C 15.8 5.5 2.4 
 155 9.5A 9.6AB 9.5A 9.4BC 9.1BC 21.9 7.4 2.5 
 181 9.5A 9.7A 9.7A 9.6A 9.5A 25.0 6.1 4.1 
 224 9.4AB 9.6A 9.5A 9.6A 9.3AB 13.8 6.0 2.3 
 228 9.5A 9.6AB 9.5A 9.4BC 9.4A 20.5 5.3 1.6 
 249 9.0C 9.4B 9.2B 9.2C 9.1BC 15.7 2.3 1.4 
          
Heat-
treated 
120 7.3D 8.4C 8.1C 8.3BC 8.1B 2.2 1.6 0.2 
 155 8.4B 8.7AB 8.7A 8.6ABC 8.4AB 3.1 0.7 0.4 
 181 7.9C 8.8A 8.8A 8.7AB 8.6A 4.7 1.7 1.6 
 224 8.8A 8.5BC 8.7A 8.7A 8.6A 5.4 1.1 0.7 
 228 7.8C 8.9A 8.6AB 8.4ABC 8.4AB 3.2 2.1 0.4 
 249 7.3D 8.6BC 8.3BC 8.2C 8.3AB 1.6 1.3 0.2 
 
3.4.1 Metabolic profiling by 1H-NMR 
Using the compound library and data available in the internet browser 
databases, a total of 29 different compounds were identified in the fermented 
barley samples (Table 5 in Paper I). Identified compounds included major 
metabolites such as acetate, ethanol, lactate, mannitol and succinate, as well as 
monosaccharides and disaccharides such as fructose, glucose, maltose and 
sucrose. These compounds were expected, since they are part of the metabolic 
pathway for fermenting simple carbohydrates used by L. reuteri (Figure 5). 
Comparing the results from unfermented barley flours revealed which 
compounds were produced and which were consumed. In untreated flour the 
main source of energy seemed to be glucose, followed by maltose, since the 
consumption of these two monosaccharides was highest. As in previous studies 
on L. reuteri from sourdoughs, the strains used in Paper I seemed to use 
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fructose, fumarate and malate as electron acceptors, forming mannitol and 
succinate (Stolz et al., 1995). Even though samples from fermented barley still 
contained fructose and in some cases fumarate and malate, the strains produced 
ethanol in similar concentrations to lactate. The production of ethanol by LAB 
leads to a lower net gain of ATP per glucose consumed (Axelsson, 2004), but 
electron acceptors are produced instead of ATP and can later be used to 
achieve higher energy yields. There are advantages that might explain the 
increase in ethanol production seen in barley flour fermented by L. reuteri. 
Higher concentrations of ethanol in the barley flour could give an competitive 
advantage over other bacteria, since LAB are known to tolerate higher 
concentrations of ethanol (Gold et al., 1992) than other bacteria such as certain 
Gram-negative species, which are more sensitive (Ingram, 1976). This could 
explain why the ethanol production was high in the untreated flours even 
though electron acceptors were still present. In heat-treated flours the main 
source of energy appeared to be maltose and sucrose, since only low 
concentrations of glucose were detected in the unfermented flours. Since 
similar concentrations of succinate and mannitol were produced in both heat-
treated and untreated flour, it is likely that the main electron acceptors were 
fumarate, malate and fructose. Lower concentrations of ethanol, lactate and 
acetate in the heat-treated compared with the untreated flour suggest that lack 
of monosaccharides (glucose and maltose) and not lack of electron acceptors 
(fructose, fumarate and malate) is the limiting factor for growth. This could 
explain the lower growth and higher pH seen in heat-treated flour fermented by 
L. reuteri. The higher growth and lower pH in heat-treated flour fermented by 
L. plantarum correlated to higher production of lactate. This indicates that L. 
plantarum can degrade polysaccharides or oligosaccharides to fermentable 
sugars. Differences were also observed in the metabolism of the L. reuteri 
strains, particularly in the production of succinate. One of the human probiotic 
strains (DSM 17938) had significantly lower production of succinate in both 
untreated and heat-treated flours of all barley varieties. These results could 
suggest that DSM 17938 did not use fumarate and malate as a source of 
electron acceptors, leading to the production of succinate. However, the results 
from the NMR analysis did not reveal any differences in the concentrations of 
malate and fumarate compared with the samples fermented by the other strains. 
The lower concentrations of succinate and similar concentrations of malate and 
fumarate could therefore indicate that the two latter compounds are used for 
the production of compounds other than succinate. Other species of lactobacilli 
are known to degrade malate and fumarate to lactate using malolactic enzymes 
(Stolz et al., 1995), but this has never been detected in L. reuteri. Further 
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analysis of this is needed before any conclusions can be drawn regarding the 
presence and activity of such enzymes in this strain. 
For most L. reuteri strains, the difference in concentrations of sugars could 
partially explain the difference seen in growth on each of the barley varieties. 
However, even though the concentrations of detected sugars were lower in 
some varieties compared with others, the growth was still higher. In an attempt 
to understand the relationship between growth of each individual strain and 
available sugars, sources of electron acceptors and amino acids, the results 
from the growth analysis was compared with the concentration of these 
compounds in the unfermented samples (Table 1). This revealed correlations 
between growth and sugar content and amino acid content, at least when 
comparing the heat-treated barley varieties with the lowest growth of L. reuteri 
to the varieties with the highest growth. As an example, DSM 17938 had the 
highest growth density in barley variety 224 and the lowest growth density in 
barley variety 120 and 249. Unfermented variety 224 had the highest 
concentrations of monosaccharides and disaccharides, as well as the second 
highest concentrations of amino acids, while 120 and 249 had the lowest 
concentrations of both groups of compounds. There was not a perfect 
correlation between sugar content, amino acid content and growth density, 
however, as seen e.g. in the growth of DSM 17938 in heat-treated flour. The 
second highest growth density was seen in barley variety 155, which had lower 
concentrations of both total sugar and total amino acid content than barley 
varieties 181 and 224, both of which had significantly lower growth density of 
DSM 17938. The ability of some L. reuteri strains to use sources other than 
available monosaccharides and disaccharides for energy could explain the 
results seen for e.g. barley variety 155 fermented by DSM 17938. 
Polysaccharide- or oligosaccharide-degrading enzymes with the ability to 
hydrolyse the complex sugars present in higher amounts in some of the barley 
varieties could be present and active in some L. reuteri strains and not in 
others. Such strain-specific enzymes have been observed in other studies 
(Saulnier et al., 2011). 
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Figure 5. Metabolic pathways of L. reuteri during the fermentation of barley flour, based on 
previously published information (Stolz et al., 1995). Compounds are colour-coded according to 
their presence in samples analysed in this study and are marked as either identified (purple) or 
unidentified (orange) based on the results from the 1H-NMR analysis. Most compounds were 
found in all samples with a few exceptions, e.g. 1,3-propanediol was only found in flour 
fermented with DSM 17938 and ATCC PTA 6475. 
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3.4.2 Potentially bioactive compounds in fermented barley 
In addition to analysis of the normal metabolites produced during fermentation 
of barley flour by the different bacterial strains, differences in the production of 
possible bioactive compounds were studied. During a literature search, a few 
interesting bioactive compounds which can be produced by L. reuteri during 
the fermentation of different substrates were discovered. The plausible 
presence of these metabolites was targeted in the analysis for bioactive 
compounds, in addition to the search for novel metabolites. Through the use of 
1H-NMR and the different online compound libraries, some of these bioactive 
compounds were identified in the samples. One such compound was GABA, 
which was found in all samples (untreated, heat-treated and unfermented), 
suggesting that it was present in the flour from the start. An increase in the 
concentration of GABA was seen in some fermented samples compared with 
unfermented, while other fermented samples showed a decrease in the 
concentrations. The increase in concentration was low and no correlations were 
found between increased GABA and use of a specific strain of bacteria. This 
indicates that there was no or only minor production of GABA during the 
fermentation of the different barley varieties. However, there were significant 
differences between barley varieties and between flour treatments. In heat-
treated flour, the concentrations of GABA decreased by more than 60%. These 
observations suggest that the variety and treatment of the flour are important 
for the initial content of GABA in barley. The low or no production of GABA 
in these samples could have been due to the short incubation time, as previous 
studies have shown that the production of GABA increases over time for up to 
96 hours (Stromeck et al., 2011). According to the same study the production 
of GABA could be strain-specific, but no conclusion can be drawn about the 
strains used in this thesis until further experiments have been performed. 
No other bioactive compounds were found using the chemical analysis 
methods applied in Paper I. However, one compound was identified in samples 
fermented by the two human probiotic strains, which could indicate the 
formation of yet another bioactive compound. In all barley varieties fermented 
by these two strains, 1,3-propanediol was detected. As explained in the 
introduction, some strains of L. reuteri are able to produce the antimicrobial 
substance reuterin by fermentation of glycerol. Since reuterin can be further 
reduced into 1,3-propanediol, the presence of this compound indicates that 
reuterin has been produced. The NMR-spectra for 3-hydroxypropionaldehyde 
(reuterin) is not included in any of the databases or libraries of compounds 
used in Paper I, making identification of the actual bioactive substance 
impossible (for now) using 1H-NMR. However, since both of these strains of 
L. reuteri tested positive for the presence of the gene and for actual production 
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of reuterin, assuming that reuterin was produced could be plausible even 
though only 1,3-propanediol was detected. Additional chemical analyses are 
needed to determine the concentration of reuterin produced during 
fermentation. Another indication of production of reuterin could be 
consumption of glycerol. Unfortunately, identification of glycerol was difficult 
or near impossible using 1H-NMR, since the spectrum for glycerol is located 
within a large cluster of other compounds, making it difficult to isolate from 
these compounds. 
3.5 Evaluation of fermented barley in a cell model (Paper II) 
In order to select a potential health promoting synbiotic formulation, it is 
important to evaluate that formulation using different models. Before 
proceeding to more expensive experiments such as animal models and clinical 
studies, it is important to establish that the formulation could actually have an 
effect using e.g. an in vitro model. In Paper II, the synbiotic formulations were 
evaluated using an epithelial cell model with the small intestinal cell line 
IPEC-J2. 
3.5.1 Intestinal permeability in an intestinal epithelial cell model 
IPEC-J2 is a non-transformed epithelial cell line isolated from the mid-jejunum 
of a neonatal piglet (Berschneider, 1989). This cell line has been widely used 
to study and characterise the epithelial cell interactions with pathogenic 
bacteria and viruses, especially focusing on the effect of pathogens such as 
Escherichia coli and Salmonella enterica (Brosnahan & Brown, 2012). The 
IPEC-J2 cell line has also been used for determining the adhesion of probiotics 
to cells and their ability to inhibit pathogen-induced inflammatory responses. 
In Paper II, the cell line was used for evaluating the effect of synbiotic 
formulations on the permeability of the cell layer and their protection against 
the pathogen enterotoxigenic E. coli (ETEC). As mentioned in the introduction, 
L. reuteri has been shown to inhibit the disruptive effect of ETEC on cell layer 
permeability (Liu, 2013). In order to determine whether metabolites produced 
by L. reuteri during the fermentation of barley have an effect against increased 
intestinal permeability, IPEC-J2 cells were pre-treated with the supernatant 
used in the chemical analysis. Pre-treated cells were then challenged with 
ETEC and the permeability was measured by transepithelial electric resistance 
(TEER) and by measuring the leakage of the fluorescent probe fluorescein 
isothiocyanate-dextran (FITC-dextran, 4kDa). 
Early experiments on the IPEC-J2 cells revealed that supernatant from both 
fermented and unfermented barley flour caused an increase in the permeability 
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of the cell layer by itself (Figure 1 & 2 in Paper II). This increase in 
permeability was immediate and no recovery of the permeability was seen after 
24 hours. Treatment with supernatant from heat-treated flour, on the other 
hand, led to a small decrease in permeability after a few hours, but complete 
recovery was achieved within six hours of treatment. Since the use of untreated 
flours itself caused an increase in permeability, these samples were not 
evaluated for their protective effect against ETEC. Further experiments were 
instead performed on samples from heat-treated flour and the effects compared 
with those of live probiotic bacteria. 
In a final sub-experiment, a few selected heat-treated barley flour samples 
fermented by the two human probiotic strains were evaluated for their 
inhibition against the disruptive effect of ETEC on the permeability of the cell 
layer of IPEC-J2 cells. Pre-treatments were performed in triplicate and the 
effect of the synbiotic metabolites was compared to that of live bacteria using 
the same two human L. reuteri strains. After six hours of pre-treatment, the 
cells were challenged with ETEC for another six hours with TEER measured 
every other hour and a sample for the FITC-dextran assay was taken after six 
hours. The results showed that the pre-treatments did not have any protective 
effect against the disruption of cell layer permeability caused by ETEC in 
terms of TEER (Figure 3 in Paper II). The results from the FITC-dextran assay, 
on the other hand, showed a significant decrease in leakage in all but one pre-
treatment compared with the untreated cells challenged with ETEC (Figure 4 in 
Paper II). Promising as these results are, they are only preliminary because of 
some problems with major variations in leakage seen in the untreated cells 
used as a control. Further experiments with fully functional controls are needed 
to confirm these observations. 
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4 Summary 
The main findings in this thesis can be summarised as follows: 
 
¾ Lactobacillus reuteri was successfully detected in, and isolated from, 
sourdoughs made from German rye flour and Chinese buckwheat and millet 
flour. This confirms the hypothesis that L. reuteri can be a frequent member 
of sourdoughs fermented at higher temperatures. However, L. reuteri was 
not detected in, or isolated from, any of the Swedish flours tested.  
 
¾ Characterisation of the isolated strains of L. reuteri by various methods 
gave similar conclusions as previous studies on the origin of these 
sourdough strains. According to the results in this thesis, the most likely 
origin of the strains is contamination by rodent faeces. 
 
¾ The fact that L. reuteri can grow well in cereal substrates was confirmed 
using six barley varieties with slightly different fibre composition and 
content. Bacterial counts ranged from 7.3-9.7 log10 CFU/g, which was 
similar to previous published values. The pH of barley fermented by L. 
reuteri reached similar or even lower values (3.4-5.3) compared with 
previous studies. Both strain- and species-specific differences in growth and 
pH reduction were observed, the most prominent being that L. plantarum 
36E was able to grow better, and lower the pH more, than L. reuteri in heat-
treated flour. Differences between L. reuteri strains were also mainly seen 
in heat-treated flour. DSM 17938 reached significantly higher growth 
density in two of the barley varieties, while two varieties gave significantly 
lower growth than all the other varieties. The growth density of the other 
strains, on the other hand, reached similar levels regardless of which barley 
variety they fermented. The differences between the two varieties with the 
highest growth of DSM 17938 and the two with the lowest can partly be 
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explained by the concentrations of available monosaccharides, 
disaccharides and amino acids. The results for DSM 17938 suggest that this 
strain is more dependent on easily available nutrients than the other strains 
for growth within 24 hours.  
 
¾ Analysing the metabolism of L. reuteri and L. plantarum in different barley 
varieties using 1H-NMR revealed species- and strain-specific differences 
and similarities. One of the more noticeable differences between species of 
bacteria was that L. plantarum produced higher concentrations of lactate in 
heat-treated flours, suggesting that it could utilise carbohydrates present in 
barley that were not available to L. reuteri. This production of lactate was 
correlated with higher growth and lower pH in the samples fermented by L. 
plantarum. Strain-specific differences observed included e.g. a significantly 
lower concentration of succinate produced by one of the human probiotic 
strains (DSM 17938) in all barley varieties and in both flour treatments. 
Samples fermented with ATCC PTA 6475, on the other hand, contained 
lower concentrations of lactate and ethanol than all other L. reuteri strains 
in untreated flour. In heat-treated flour, the same differences in 
concentrations of lactate and ethanol were observed but they were not 
significant.  
 
¾ The search for bioactive compounds produced by L. reuteri during the 
fermentation of barley flours using the methods available in this thesis only 
led to possible evidence of the production of reuterin. This evidence, in the 
form of production of 1,3-propanediol, was only detected in samples 
fermented with the two probiotic strains of human origin, ATCC PTA 6475 
and DSM 17938. One other bioactive compound (GABA) was found to be 
present, but no significant production of this compound was detected by L. 
reuteri in the fermented barley flours. Since the production of GABA has 
been described for L. reuteri in previous studies, the low or no production 
seen in this thesis could be due to the shorter fermentation time used here. 
 
¾ Evaluation of synbiotic formulations of barley and L. reuteri using an 
intestinal epithelial cell model (IPEC-J2) revealed that untreated barley 
flour increased the permeability of the cell layer, while heat-treated flour 
did not. Pre-treatment of the intestinal cells with different synbiotic 
formulations and live probiotic bacteria before a challenge with ETEC 
revealed that some of these pre-treatments had a potentially protective 
effect against the leakage of large molecules (FITC-dextran). However, 
none of the pre-treatments gave a protective effect against increased cell 
permeability as measured by TEER. 
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5 Future perspectives 
Based on the results presented in this thesis, further research is needed in the 
following areas: 
Metabolic profiles of fermented foods 
The software used for the identification of compounds in 1H-NMR has its 
limitations, since it only contains the spectra of a total of 300 compounds. 
While the use of internet metabolome databases provides additional thousands 
of metabolites for the identification of metabolites, it does not help in the 
quantification of these metabolites. Parts of the spectra in this thesis were also 
left unidentified because of clustering of compounds, which made it impossible 
to single out individual compounds. Additional methods for the analysis of 
metabolites might be needed to provide a complete metabolic profile of each 
sample. Methods such as 2D-NMR and LC-MS could help achieve a more 
complete picture of the metabolic profiles. Use of these combinations of 
methods has been tested and proposed in other studies (Pan & Raftery, 2007). 
Production of bioactive compounds 
Since only a few bioactive compounds could be detected using the chemical 
analysis used in this study, different methods for analysis might be needed. For 
example, HPLC can be successfully used in detecting the production or release 
of phenolic acids (Hole et al., 2012). Other methods including GC-MS and LC-
MS have also been used for the detection of possible bioactive compounds in 
fermented cereals, with good results (Gorzolka et al., 2012; Hu et al., 2011). 
These are methods that could be used in combination with 1H-NMR for better 
coverage when screening combinations of cereal flour and probiotic bacteria 
for the production of possible bioactive compounds. Prolongation of the 
fermentation time to 48 or even 96 hours might also be necessary, since it has 
been shown that the production of bioactive compounds such as GABA 
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increases with longer fermentation times (Stromeck et al., 2011). In order to 
find better synbiotic combinations, additional cereals or sub-cereals could also 
be analysed for their presence of bioactive compounds, since an increase in 
production has been seen in fermentation of e.g. sorghum (Coda et al., 
2010Coda et al., 2010). 
Evaluation of synbiotic formulations in intestinal cell models 
The results from the experiments using the IPEC-J2 model are preliminary and 
additional experiments are needed before any conclusions can be drawn about 
the effect on intestinal permeability. Because of the disruptive effect of the 
fermented and unfermented, untreated barley flour, one could argue that the 
choice of cereal might be important for this kind of model. In order to exclude 
possible negative effects on cell membrane integrity caused by e.g. cereal 
proteins such as gliadins or glutenins, a comparison to cereals or sub-cereals 
lacking these proteins could be made, using e.g. fermented sorghum or 
buckwheat flour. The lack of effect on TEER when treating the cells with 
fermented, heat-treated barley flour could be due to the lower concentrations of 
bioactive compounds in these samples compared with the untreated barley 
flours. An increase in these concentrations might be possible with longer 
fermentation times, as indicated in the previous section. Comparisons of 
fermented barley flours with different fermentation times in the cell model 
might be necessary. In addition to comparing different cereals, the use of 
another type of cell line might be necessary. IPEC-J2 is a small intestine cell 
line and since many gastrointestinal disorders also affect the large intestine, the 
use of a large intestine cell line such as Caco-2 has been suggested in order to 
fully evaluate the effect of these synbiotic formulations. 
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